<DOC>
	<DOCNO>NCT00390728</DOCNO>
	<brief_summary>Primary objective : AT.LANTUS main study* - To determine optimal treatment algorithm insulin glargine base incidence severe hypoglycaemia . ( *Target Number patient main study:2346 ) HALT Sub-study** - To test hypothesis titration regimens involve insulin glargine associate change rate symptomatic hypoglycaemic episodes together change Fear Hypoglycaemia measure HFS-98 Questionnaire Type I diabetes . ( **Target Number patient Sub-study : 250 ) Secondary objective : AT.LANTUS main study To determine : - incidence symptomatic , asymptomatic nocturnal hypoglycaemia treatment regimen - difference glycemic control measure HbA1c fast blood glucose treatment regimen - difference glycemic control measure HbA1c fast blood glucose baseline end treatment - safety use insulin glargine treatment algorithm - change subject weight treatment regimen - change insulin dose treatment regimen - change Diabetes Treatment Satisfaction ( Diabetes Treatment Satisfaction Questionnaire , sub-study ) treatment regimen HALT Sub-study ( baseline study end ) - To estimate relationship change HbA1c incidence hypoglycaemia - To examine effect insulin glargine Quality Life ( EQ-5D ) relation incidence hypoglycaemia - To examine effect insulin glargine Hospital Anxiety Depression Scale ( HADS ) relation incidence hypoglycaemia - To examine use Prescription Plan versus standard management ( Prescription Plan )</brief_summary>
	<brief_title>Insulin Glargine Type I Diabetes Mellitus &gt; Main Study `` AT.LANTUS '' : A Trial Comparing Lantus Algorithms Achieve Normal Blood Glucose Targets Subjects With Uncontrolled Blood Sugar . Sub-study : `` HALT '' ( Hypoglycaemia Avoidance With Lantus Trial )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Inclusion criterion : Subjects type 1 diabetes mellitus require basal ( longacting ) insulin control hyperglycemia , HbA1c value &gt; 7.0 % &lt; 12 % , body mass index ( BMI ) &lt; 40 kg/m2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>